Little Green Pharma Ltd (ASX:LGP)

Australia · Delayed Price · Currency is AUD

0.0870

-0.0030 (-3.33%)

May 28, 2026, 3:01 PM AEST

Revenue by Segment

Financials in millions AUD. Fiscal year is April - March.

Millions AUD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017
Pharmaceuticals			27.29M	19.86M	14.04M	7.00M	2.20M
Pharmaceuticals Growth			37.41%	41.45%	100.47%	217.77%	786.93%
Total			27.29M	19.86M	14.04M	7.00M	2.20M
Total Growth			37.41%	41.45%	100.47%	217.77%	786.93%

Revenue by Geography

Financials in millions AUD. Fiscal year is April - March.

Millions AUD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017
Australia			25.29M	19.04M	13.85M	-	2.20M
Australia Growth			32.81%	37.51%	-	-	786.93%
Europe			11.75M	3.39M	824.16K	-	-
Europe Growth			246.37%	311.65%	-	-	-
Intersegment Eliminations			-11.24M	-2.58M	-633.70K	-	-
Total			25.80M	19.86M	14.04M	-	2.20M
Total Growth			29.93%	41.45%	-	-	786.93%

Source: S&P Global Market Intelligence.